The information in this prospectus is not complete and may be changed. We may not sell these securities until the registration statement filed with the Securities and Exchange Commission is effective. This prospectus is not an offer to sell these securities and is not soliciting an offer to buy these securities in any jurisdiction where the offer or sale is not permitted.
PRELIMINARY PROSPECTUS | | | SUBJECT TO COMPLETION, DATED
MARCH 23, 2021 |
$100,000,000
MODIV ACQUISITION CORP.
10,000,000 UNITS
Modiv Acquisition Corp., which we refer to as “we,” “us” or “our company,” is a newly organized blank check company incorporated in Delaware and formed for the purpose of entering into a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization or other similar business combination with one or more businesses or entities, which we refer to throughout this prospectus as our “initial business combination.” Although we are not limited to a particular industry or geographic region for purposes of consummating an initial business combination, we intend to focus on targets located in North America that are focused on fintech and proptech, with a focus on companies whose core purpose is related to the real estate industry. Within those parameters, we intend to pursue a business combination with companies that use technology driven platforms and solutions to disrupt or revolutionize the real estate capital markets, transactional marketplaces and investment management industry.
This is an initial public offering of our securities. We are offering 10,000,000 units at an offering price of $10.00 per unit. Each unit consists of one share of common stock, par value $0.0001, and one warrant to purchase one-half (½) share of common stock, which we refer to throughout this prospectus as “warrants” or the “public warrants.” Each warrant entitles the holder thereof to purchase one-half (½) share of common stock at a price of $11.50 per whole share, subject to adjustment as described in the prospectus. We will not issue fractional shares. As a result, you must exercise public warrants in multiples of two warrants, at a price of $11.50 per whole share, subject to adjustment as described in this prospectus, to validly exercise your warrants. Each public warrant will become exercisable on the later of (i) one year after the effective date of the registration statement of which this prospectus forms a part, and (ii) the consummation of an initial business combination, and will expire five years after the completion of an initial business combination, or earlier upon redemption.
We have granted Chardan Capital Markets LLC, the representative of the underwriters, a 45-day option to purchase up to an additional 1,500,000 units (over and above the 10,000,000 units referred to above) solely to cover over-allotments, if any.
We will provide the holders of our outstanding shares of common stock that were sold as part of the units in this offering with the opportunity to redeem their shares of common stock upon the consummation of our initial business combination at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the trust account described below, including interest (net of taxes payable), divided by the number of then outstanding shares of common stock that were sold as part of the units in this offering, which we refer to as our “public shares.”
We have 24 months to consummate our initial business combination. If we are unable to consummate our initial business combination within the above time period, we will distribute the aggregate amount then on deposit in the trust account, pro rata to our public stockholders, by way of the redemption of their shares and thereafter cease all operations except for the purposes of winding up of our affairs, as further described herein. In such event, the warrants will expire and be worthless.
On January 29, 2021, Modiv Venture Fund, LLC, an entity affiliated with Modiv Inc. and certain of our management team, which we refer to as our “sponsor,” purchased 2,875,000 shares, which includes an aggregate of up to 375,000 shares that are subject to forfeiture to the extent that the underwriters’ over-allotment option is not exercised in full or in part, for an aggregate purchase price of $25,000, which we refer to herein as “founder shares” or “insider shares.”
Our sponsor has committed to purchase from us an aggregate of 8,400,000 (or 9,000,000 if the over-allotment option is exercised in full) warrants (or “private warrants”) at $0.50 per private warrant for a total purchase price of $4,200,000 (or $4,500,000 if the over-allotment option is exercised in full). Each private warrant is exercisable for one-half (½) share of common stock at an exercise price of $11.50 per whole share. These purchases will take place on a private placement basis simultaneously with the consummation of this offering. Of the $4,200,000 (or $4,500,000 if the over-allotment option is exercised in full) we will receive from the sale of the private warrants, $3,200,000 will be used for offering expenses (not including deferred underwriting discounts) and $1,000,000 will be used for working capital held outside of the trust account (or $3,500,000 will be used for offering expenses if the over-allotment option is exercised in full).
There is presently no public market for our units, common stock, or warrants. We intend to apply to have our units listed on the NYSE American under the symbol “MACSU” on or promptly after the date of this prospectus. We cannot guarantee that our securities will be approved for listing on NYSE American. Once the securities comprising the units begin separate trading as described in this prospectus, the units, shares of common stock and warrants will be traded on NYSE American under the symbols “MACSU”, “MACS” and “MACSW,” respectively. We cannot assure you that our securities will continue to be listed on NYSE American after this offering.
We are an “emerging growth company” as defined in the Jumpstart Our Business Startups Act of 2012 and will therefore be subject to reduced public company reporting requirements.
Investing in our securities involves a high degree of risk. See “Risk Factors” beginning on page
27 of this prospectus for a discussion of information that should be considered in connection with an investment in our securities.
Neither the Securities and Exchange Commission (the “SEC”) nor any state securities commission has approved or disapproved of these securities or determined if this prospectus is truthful or complete. Any representation to the contrary is a criminal offense.
Per unit | | | $10.00 | | | $0.55(2) | | | $9.45 |
Total | | | $100,000,000 | | | $5,500,000 | | | $94,500,000 |
(1)
| Please see the section titled “Underwriting” for further information relating to the underwriting arrangements agreed to between us and the underwriters in this offering. |
(2)
| Includes $3,500,000, or $0.35 per unit, equal to 3.5% of the gross proceeds of this offering (or $4,025,000 if the underwriters’ over-allotment option is exercised in full) payable to the underwriters as deferred underwriting discounts and commissions from the funds to be placed in the trust account described below. Such funds will be released to the underwriters only upon consummation of an initial business combination, as described in this prospectus. If the business combination is not consummated, such deferred discount will be forfeited by the underwriters. The underwriters will not be entitled to any interest accrued on the deferred underwriting discount. |
Upon consummation of the offering, $10.00 per unit sold to the public in this offering (whether or not the over-allotment option has been exercised in full or part) will be deposited into a United States-based trust account, with American Stock Transfer & Trust Company, LLC, acting as trustee. Such amount includes $3,500,000, or $0.35 per unit (or $4,025,000 if the underwriters’ over-allotment option is exercised in full) payable to the underwriters as deferred underwriting discounts and commissions. Except as described in this prospectus, these funds will not be released to us until the earlier of the completion of our initial business combination and our redemption of the public shares upon our failure to consummate a business combination within the required period.
The underwriters are offering the units on a firm commitment basis. The underwriters expect to deliver the units to purchasers on or about [•], 2021.
Sole Book-Running Manager
Chardan
[•], 2021